ABVC BioPharma, Inc. (ABVC)
NASDAQ: ABVC · Real-Time Price · USD
0.9843
+0.0078 (0.80%)
Apr 28, 2025, 4:00 PM EDT - Market closed

ABVC BioPharma Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2015 - 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
Revenue
0.510.150.970.360.48
Upgrade
Revenue Growth (YoY)
234.31%-84.28%172.57%-26.34%-31.16%
Upgrade
Cost of Revenue
00.30.290.010.02
Upgrade
Gross Profit
0.51-0.150.680.350.46
Upgrade
Selling, General & Admin
2.265.376.075.754.27
Upgrade
Research & Development
0.181.062.6910.55
Upgrade
Operating Expenses
5.216.6215.812.068.97
Upgrade
Operating Income
-4.71-6.77-15.11-11.71-8.51
Upgrade
Interest Expense
-0.83-1.31-0.29-0.23-0.41
Upgrade
Interest & Investment Income
0.090.190.190.040.07
Upgrade
Currency Exchange Gain (Loss)
-0.030.02-0.260.43-0
Upgrade
Other Non Operating Income (Expenses)
0.180.070.080.160.2
Upgrade
EBT Excluding Unusual Items
-5.29-7.8-15.4-11.3-8.64
Upgrade
Gain (Loss) on Sale of Investments
-0.34-0.22-0.01-0.27-2.17
Upgrade
Asset Writedown
---0.11--
Upgrade
Other Unusual Items
0.26--0.36-
Upgrade
Pretax Income
-5.37-8.02-15.51-11.21-10.81
Upgrade
Income Tax Expense
-0.110.260.80.83-0.22
Upgrade
Earnings From Continuing Operations
-5.26-8.28-16.31-12.04-10.59
Upgrade
Minority Interest in Earnings
0.360.49-0.11-0.80.8
Upgrade
Net Income
-4.9-7.79-16.42-12.84-9.79
Upgrade
Net Income to Common
-4.9-7.79-16.42-12.84-9.79
Upgrade
Shares Outstanding (Basic)
124332
Upgrade
Shares Outstanding (Diluted)
124332
Upgrade
Shares Change (YoY)
169.26%36.92%26.39%27.07%12.67%
Upgrade
EPS (Basic)
-0.42-1.80-5.19-5.12-4.97
Upgrade
EPS (Diluted)
-0.42-1.80-5.19-5.12-5.00
Upgrade
Free Cash Flow
-1.81-4.21-7.52-7.62-4.56
Upgrade
Free Cash Flow Per Share
-0.15-0.97-2.37-3.04-2.31
Upgrade
Gross Margin
99.85%-98.15%70.47%98.57%96.13%
Upgrade
Operating Margin
-923.34%-4439.24%-1558.54%-3290.07%-1760.87%
Upgrade
Profit Margin
-962.12%-5109.26%-1693.50%-3608.47%-2026.97%
Upgrade
Free Cash Flow Margin
-355.02%-2760.64%-775.23%-2140.33%-944.82%
Upgrade
EBITDA
-4.67-6.74-15.09-11.69-8.47
Upgrade
D&A For EBITDA
0.030.030.020.010.04
Upgrade
EBIT
-4.71-6.77-15.11-11.71-8.51
Upgrade
Updated Nov 14, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q